After the hype, HOPE (and HPS): some lessons from the Women's Health Initiative trial, the Heart Outcomes Prevention Evaluation study and the Heart Prevention Study.
Paulo Andrade
PA
Lotufo
D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000009:adverse effects; D001161:Arteriosclerosis / Q000453:epidemiology; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D015984:Causality; D002986:Clinical Trials as Topic; D015914:Estrogen Replacement Therapy / Q000009:adverse effects; D005260:Female; D006801:Humans; D008012:Lidocaine / Q000008:administration & dosage / Q000009:adverse effects; D016387:Women's Health
D000889:Anti-Arrhythmia Agents; D008012:Lidocaine